Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Immunocore brings in record $320mm through Series A round

Executive Summary

Immunocore Ltd. (T-cell receptor-based therapies for cancer, infections, and autoimmune diseases) raised $320mm through its Series A round. New investors Woodford Investment Management, partner Eli Lilly & Co., RTW Investments, and Malin Corp. PLC (which invested $80mm) participated, along with additional new and returning buyers.
Deal Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies